Protagenic Therapeutics, Inc. is a biotechnology company, which specializes in the discovery and development of therapeutics to treat central nervous system disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
161158413
Latest filings (excl ownership)
15-12G
Securities registration termination
3 Mar 14
EFFECT
Notice of effectiveness
28 Feb 14
POS AM
Prospectus update (post-effective amendment)
26 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 14
25-NSE
Exchange delisting
19 Feb 14
8-K
Completion of Acquisition or Disposition of Assets
19 Feb 14
DEFA14A
Additional proxy soliciting materials
10 Feb 14
8-K
Other Events
7 Feb 14
Latest ownership filings
SC 13G/A
Performance Technologies Inc \De\
17 Feb 15
SC 13G/A
Performance Technologies Inc \De\
5 Feb 15
SC 13G/A
Performance Technologies Inc \De\
27 Feb 14
SC 13G/A
Performance Technologies Inc \De\
13 Feb 14
SC 13G/A
Performance Technologies Inc \De\
10 Feb 14
SC 13G/A
Performance Technologies Inc \De\
11 Dec 13